Ibrahim NK - Search Results

1

Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors.

Gerber DE, Stopeck AT, Wong L, Rosen LS, Thorpe PE, Shan JS, Ibrahim NK. Gerber DE, et al. Among authors: ibrahim nk. Clin Cancer Res. 2011 Nov 1;17(21):6888-96. doi: 10.1158/1078-0432.CCR-11-1074. Epub 2011 Oct 11. Clin Cancer Res. 2011. PMID: 21989064 Clinical Trial.

2

Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.

Hoff PM, Valero V, Ibrahim N, Willey J, Hortobagyi GN. Hoff PM, et al. Cancer. 1998 Mar 1;82(5):965-9. doi: 10.1002/(sici)1097-0142(19980301)82:5<965::aid-cncr23>3.0.co;2-y. Cancer. 1998. PMID: 9486588 Clinical Trial.

3

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

Ibrahim NK, Rahman Z, Valero V, Willey J, Theriault RL, Buzdar AU, Murray JL 3rd, Bast R, Hortobagyi GN. Ibrahim NK, et al. Cancer. 1999 Oct 1;86(7):1251-7. doi: 10.1002/(sici)1097-0142(19991001)86:7<1251::aid-cncr21>3.0.co;2-f. Cancer. 1999. PMID: 10506711 Clinical Trial.

4

Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.

Ibrahim NK, Valero V, Theriault RL, Willey J, Walters RS, Buzdar AU, Booser DJ, Hortobagyi GN. Ibrahim NK, et al. Am J Clin Oncol. 2000 Apr;23(2):117-21. doi: 10.1097/00000421-200004000-00003. Am J Clin Oncol. 2000. PMID: 10776969 Clinical Trial.

5

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA. Ibrahim NK, et al. Clin Cancer Res. 2002 May;8(5):1038-44. Clin Cancer Res. 2002. PMID: 12006516 Clinical Trial.

6

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Buzdar AU, Singletary SE, Valero V, Booser DJ, Ibrahim NK, Rahman Z, Theriault RL, Walters R, Rivera E, Smith TL, Holmes FA, Hoy E, Frye DK, Manuel N, Kau SW, McNeese MD, Strom E, Thomas E, Hunt K, Ames F, Berry D, Hortobagyi GN. Buzdar AU, et al. Among authors: ibrahim nk. Clin Cancer Res. 2002 May;8(5):1073-9. Clin Cancer Res. 2002. PMID: 12006521 Clinical Trial.

7

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.

Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: ibrahim nk. Clin Cancer Res. 2002 Nov;8(11):3360-8. Clin Cancer Res. 2002. PMID: 12429622 Clinical Trial.

8

Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.

Murray JL, Gillogly ME, Przepiorka D, Brewer H, Ibrahim NK, Booser DJ, Hortobagyi GN, Kudelka AP, Grabstein KH, Cheever MA, Ioannides CG. Murray JL, et al. Among authors: ibrahim nk. Clin Cancer Res. 2002 Nov;8(11):3407-18. Clin Cancer Res. 2002. PMID: 12429628

9

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

Kantarjian HM, Gandhi V, Kozuch P, Faderl S, Giles F, Cortes J, O'Brien S, Ibrahim N, Khuri F, Du M, Rios MB, Jeha S, McLaughlin P, Plunkett W, Keating M. Kantarjian HM, et al. J Clin Oncol. 2003 Mar 15;21(6):1167-73. doi: 10.1200/JCO.2003.04.031. J Clin Oncol. 2003. PMID: 12637486 Clinical Trial.

10

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer.

Trent JC, Valero V, Booser DJ, Esparza-Guerra LT, Ibrahim N, Rahman Z, Vernillet L, Patel S, David CL, Murray JL, Cristofanilli M, Hortobagyi GN. Trent JC, et al. Clin Cancer Res. 2003 Jul;9(7):2426-34. Clin Cancer Res. 2003. PMID: 12855614 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters